Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

U.S. FDA approves new protocol for study on Bayer's birth control device

December 20, 2018 7:26 PM
90 0

(Reuters) - The U.S. Food and Drug Administration on Thursday approved a new protocol for a post-marketing study of Bayer AG’s Essure birth-control device, as the regulator seeks more information on the device’s safety.

The study would now monitor here women implanted with the devices for five years, up from three years, and would need additional blood tests.

Read more

Share in social networks:

Comments - 0